Our products
GLP-1 receptor agonist
Semaglutide
A GLP-1 analogue that activates receptors involved in glucose control and appetite signalling.
How it works
GLP-1 receptor activation increases glucose-dependent insulin secretion and reduces glucagon secretion. It also affects appetite signalling and can slow gastric emptying.
Research context
Semaglutide is the active ingredient in approved prescription medicines for specific indications. Those approvals apply to regulated medicinal products, not laboratory research peptides.